BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30547014)

  • 1. Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice.
    Chovanec M; Albany C; Mego M; Montironi R; Cimadamore A; Cheng L
    Front Oncol; 2018; 8():571. PubMed ID: 30547014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.
    Aparicio J; Sánchez-Muñoz A; Ochenduszko S; Gumà J; Fernández-Aramburo A; García Del Muro X; Quiroga V; Sastre J; Alonso-Gordoa T; Sagastibelza N; Maroto P; Gómez de Liaño A; Vázquez S; Diz P; Durán I; Domenech M; Pinto A; Hernández A; González-Billalabeitia E; Terrasa J
    J Urol; 2019 Oct; 202(4):742-747. PubMed ID: 31163007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.
    Kojima T; Kawai K; Tsuchiya K; Abe T; Shinohara N; Tanaka T; Masumori N; Yamada S; Arai Y; Narita S; Tsuchiya N; Habuchi T; Nishiyama H
    Int J Urol; 2015 Oct; 22(10):923-7. PubMed ID: 26094715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testicular Cancer Biomarkers: A Role for Precision Medicine in Testicular Cancer.
    Leão R; Ahmad AE; Hamilton RJ
    Clin Genitourin Cancer; 2019 Feb; 17(1):e176-e183. PubMed ID: 30497810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reclassification of good-risk seminoma: prognostic factors, novel biomarkers and implications for clinical management.
    Casadei C; Schepisi G; Menna C; Chovanec M; Gurioli G; Gallà V; Altavilla A; Marcellini M; Bellia SR; Lolli C; Mego M; Rosti G; De Giorgi U
    Future Oncol; 2019 Apr; 15(12):1347-1352. PubMed ID: 30880465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is gynecomastia related to the disease characteristics and prognosis in testicular germ cell tumor patients?
    Polat AV; Öztürk M; Çamlıdağ İ; Akyüz B
    Diagn Interv Radiol; 2019 May; 25(3):189-194. PubMed ID: 31063146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors.
    von Eyben FE
    Clin Biochem; 2001 Sep; 34(6):441-54. PubMed ID: 11676973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Lactate Dehydrogenase in Identifying Relapse for Patients With Stage I Testicular Cancer on Surveillance.
    Bobrowski A; Anson-Cartwright L; Kuhathaas K; Jiang DM; Chung P; Bedard P; Warde P; O'Malley M; Sweet J; Hamilton RJ
    J Urol; 2022 Dec; 208(6):1250-1258. PubMed ID: 35997696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Circulating Tumor Cells (CTCs) in Patients with Testicular Germ Cell Tumors.
    Nastały P; Honecker F; Pantel K; Riethdorf S
    Methods Mol Biol; 2021; 2195():245-261. PubMed ID: 32852768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.
    Syring I; Bartels J; Holdenrieder S; Kristiansen G; Müller SC; Ellinger J
    J Urol; 2015 Jan; 193(1):331-7. PubMed ID: 25046619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular cancer: new developments, molecular pathology, and current research keynote.
    Lopez-Beltran A
    Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):204-207. PubMed ID: 37975918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.
    J Clin Oncol; 1997 Feb; 15(2):594-603. PubMed ID: 9053482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
    Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
    Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumors.
    Grundner-Culemann E; Bokemeyer C; Neubauer V; Shalitin C; Schmoll HJ; Poliwoda H; Benter T
    J Cancer Res Clin Oncol; 1993; 119(11):685-8. PubMed ID: 8394368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular Germ Cell Tumors: Serological and Immunohistochemical Diagnosis.
    Damjanov I
    Acta Med Acad; 2021 Apr; 50(1):58-70. PubMed ID: 34075764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Kawai T; Tanaka Y;
    Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Verification of testicular cancer guidelines].
    Nonomura N; Azuma H
    Hinyokika Kiyo; 2012 Dec; 58(12):713-4. PubMed ID: 23328171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of vital germ cell tumor cells in short-term cell cultures of primary tumors and of retroperitoneal metastasis--clinical implications.
    Otto T; Virchow S; Fuhrmann C; Steinberg F; Streffer C; Goepel M; Rübben H
    Urol Res; 1997; 25(2):121-4. PubMed ID: 9144879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.
    von Eyben FE; Blaabjerg O; Hyltoft-Petersen P; Madsen EL; Amato R; Liu F; Fritsche H
    Clin Chem Lab Med; 2001 Jan; 39(1):38-44. PubMed ID: 11256799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.